Dr. Armstrong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1991
- UPMC Medical EducationResidency, Internal Medicine, 1984 - 1987
- George Washington University School of Medicine and Health SciencesClass of 1984
Certifications & Licensure
- MD State Medical License 1988 - 2024
- VA State Medical License 2022 - 2024
- PA State Medical License 1986 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- America's Top Doctors for Cancer Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Clinical Trials
- Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer Start of enrollment: 1994 Oct 21
- Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer Start of enrollment: 1998 Mar 01
- Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2000 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 194 citationsSurvival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz> ;Journal of Clinical Oncology. 2023 Sep 1
- 3 citationsCombination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.Stephanie L Wethington, Payal D Shah, Lainie Martin, Janos L Tanyi, Nawar Latif, Mark Morgan, Drew A Torigian, Diego Rodriguez, Simon A Smith, Emma Dean, Susan M Domch...> ;Clinical Cancer Research. 2023 Aug 1
- 3 citationsRandomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.Thomas J Herzog, Sandro Pignata, Sharad A Ghamande, Maria-Jesús Rubio, Keiichi Fujiwara, Christof Vulsteke, Deborah K Armstrong, Jalid Sehouli, Robert L Coleman, Hani ...> ;Gynecologic Oncology. 2023 Mar 1
- Join now to see all
Press Mentions
- Advisers to the FDA Back First Over-the-Counter Birth Control PillMay 10th, 2023
- Hyperthermic Intraperitoneal Chemotherapy May Benefit Some Women with Ovarian CancerMarch 10th, 2022
- Drug Boosts Survival for Women with Advanced Ovarian CancerMarch 25th, 2021
- Join now to see all
Committees
- External Advisory Board Member, Fred Hutchinson Cancer Research Center, University off Washington 2017 - Present
- Scientific Advisory Committee Member, Ovarian Cancer Research Alliance 2016 - Present
- Ovarian cancer contributor, UpToDate 2014 - Present
- External Advisory Committee Member, Mayo Clinic Ovarian Cancer SPORE 2014 - Present
- Advisory Committee Member, The Marsha Rivkin Center for Ovarian Cancer Research 2008 - Present
- Member, chair 2017-2020, Department of Defense, Congressionally Directed Medical Research Program, Ovarian Cancer Research Program 2007 - Present
- Medical and Scientific Advisory Board, National Ovarian Cancer Coalition 2006 - Present
- co-Chair 2018-2020, NIH Ovarian Task Force, Gynecologic Cancer Steering Committee 2014 - 2020
- Chair, 2014-2016, Oncology Drugs Advisory Committee, FDA 2011 - 2016
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- Member
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
Industry Relationships
- Independent Data Monitoring Committee Member, DUO-E Trial, AstraZeneca2020 - Present
- Independent Data Monitoring Committee Member and Chair, DUO-O Trial, AstraZeneca2018 - Present
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/deborah-armstrong
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: